A phase I/II randomized study of Debio1143 combined with concurrent chemoradiation therapy (CCRT) in patients with locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN).
Christophe Le Tourneau
No relevant relationships to disclose
Yungan Tao
No relevant relationships to disclose
Jean-Pierre Delord
Consultant or Advisory Role - Debiopharm Group
Silvano Brienza
Employment or Leadership Position - Debiopharm Group
Gregoire Vuagniaux
Employment or Leadership Position - Debiopharm Group
Marie-Paule Sablin
No relevant relationships to disclose
Claudio Zanna
Employment or Leadership Position - Debiopharm Group
Jean Bourhis
Consultant or Advisory Role - Debiopharm Group